Subscribe to Newsletter

Search

Reset Filter
You have a filtered search result

73 search results for ‘*’

Subspecialties Cataract

The ASCRS Experience

| Jon Greenaway | 6 min read

What’s it like to go to your first big ophthalmology meeting? The Editor shares his thoughts

Business & Profession Professional Development

How To Avoid Burnout: Some Pearls of Hard Won Wisdom

| David Lockington | 6 min read

We may not always love our jobs but here’s a few ways to avoid burnout

Business & Profession Health Economics and Policy

The Importance of Choosing Your Words Carefully

| Tanya Trinh, Balamurali K. Ambati | 7 min read

Standardized terminology can enable patients to better understand their conditions and treatment options and make informed decisions

Business & Profession Health Economics and Policy

The Dangers of Talking to Artificial Strangers…

| Oscelle Boye | 4 min read

ChatGPT may be the trendy new AI to talk to but how willingly should clinicians be welcoming it into their practices?

Subspecialties Pediatric

Shutting Down Short-Sightedness

| Jon Greenaway, Oscelle Boye | 25 min read

With myopia rates increasing, how are European eye care professionals responding?

Business & Profession Professional Development

Tech Supports

| Imran Rahman | 4 min read

Incorporating technology and increased digitization is key to curbing the UK National Health Service’s crisis

Business & Profession Practice Management

TOV: Profit Over Patients?

| Oscelle Boye | 4 min read

A recent lawsuit involving Dole Veterans Affairs surgeons and Medtronic has rekindled the debate about the place of TOV payments in medicine

Subspecialties Retina

Wide Field, Deep Learning

| Pr. Eric Souied | 5 min read

How AI-assisted UWF imaging is being used to classify retinal vascular diseases

Business & Profession Health Economics and Policy

(Eye)Drop Out of Sight

| Oscelle Boye | 4 min read

What led to the recent bacterial outbreak in the USA that infected 68 and, resulted in the death of three patients?

Subspecialties Retina

Weighing the Cost

| Oscelle Boye | 4 min read

Is Ozempic’s higher rates of diabetic retinopathy and adverse ocular events compared to other GLP-1 agonists cause for concern?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: